Our study demonstrated that the prevalence of rs35829419 (Q705K, NLRP3) polymorphism is higher in subjects with pancreatic cancer and that of rs17699678 (F359L, NLRP2) polymorphism is higher in the group of chronic pancreatitis. The gene discussed is NLRP2; the disease is familial pancreatic carcinoma.